Intellia Therapeutics (NTLA) Stock: Cathie Wood’s ARK Buys Third Day Running

TLDR ARK Invest purchased 56,769 Intellia Therapeutics shares on Thursday, worth roughly $682,000 across two ETFs This marks the third straight trading day of ARK accumulating NTLA stock Intellia shares have surged 32% year-to-date after dropping 23% in 2025 following a clinical trial death The gene-editing firm is developing CRISPR-based treatments for rare diseases Analysts [...]

The post Intellia Therapeutics (NTLA) Stock: Cathie Wood’s ARK Buys Third Day Running appeared first on Blockonomi.